These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

823 related items for PubMed ID: 12491511

  • 1. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J, Zuna J, Muzíková K, Kalinová M, Krejcí O, Hrusák O, Otová B, Starý J, Trka J.
    Cancer; 2003 Jan 01; 97(1):105-13. PubMed ID: 12491511
    [Abstract] [Full Text] [Related]

  • 2. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P, Barragán E, Verdeguer A, Cervera J, Fernández JM, Moreno I, Lerma E, Esquembre C, Tasso M, Fuster V, Bermúdez M, Sanz MA.
    Haematologica; 2002 Jan 01; 87(1):23-32. PubMed ID: 11801462
    [Abstract] [Full Text] [Related]

  • 3. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
    Seeger K, Kreuzer KA, Lass U, Taube T, Buchwald D, Eckert C, Körner G, Schmidt CA, Henze G.
    Cancer Res; 2001 Mar 15; 61(6):2517-22. PubMed ID: 11289124
    [Abstract] [Full Text] [Related]

  • 4. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R.
    Clin Cancer Res; 2005 Apr 15; 11(8):2974-80. PubMed ID: 15837750
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
    Krauter J, Gorlich K, Ottmann O, Lubbert M, Dohner H, Heit W, Kanz L, Ganser A, Heil G.
    J Clin Oncol; 2003 Dec 01; 21(23):4413-22. PubMed ID: 14645432
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
    László R, Alpár D, Kajtár B, Lacza A, Ottóffy G, Kiss C, Bartyik K, Nagy K, Pajor L.
    Pediatr Blood Cancer; 2010 Jan 01; 54(1):158-60. PubMed ID: 19813247
    [Abstract] [Full Text] [Related]

  • 11. The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.
    Scholl C, Schlenk RF, Eiwen K, Döhner H, Fröhling S, Döhner K, AML Study Group.
    Haematologica; 2005 Dec 01; 90(12):1626-34. PubMed ID: 16330435
    [Abstract] [Full Text] [Related]

  • 12. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X, Li Q, Zhu YP, Zhou CY, Gao J, Li XH, Pan LL, Li FY, Tian X, Liu HT.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct 01; 24(5):560-3. PubMed ID: 17922427
    [Abstract] [Full Text] [Related]

  • 13. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
    Li ZG, Zhao W, Gao Z, Wu MY, Zhang YH, Shi HW, Xie J.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun 01; 15(3):523-7. PubMed ID: 17605858
    [Abstract] [Full Text] [Related]

  • 14. [Study of TEL-AML1 fusion gene in childhood B-lineage acute lymphoblastic leukemia].
    Niu C, Huang W, Su X.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Feb 01; 20(2):61-4. PubMed ID: 11601199
    [Abstract] [Full Text] [Related]

  • 15. [Study of the childhood acute lymphoblastic leukemia with t(12;21)].
    Lin D, Liu SH, Zhu XF, Bo LJ, Li CW, Chen YM, Liu XP, Qin S, Dai Y, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan 01; 25(1):17-21. PubMed ID: 14990071
    [Abstract] [Full Text] [Related]

  • 16. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A, Heiden T, Taube T, Körner G, Seeger K.
    Eur J Haematol; 2009 Nov 01; 83(5):420-32. PubMed ID: 19594616
    [Abstract] [Full Text] [Related]

  • 17. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
    Nakao M, Yokota S, Horiike S, Taniwaki M, Kashima K, Sonoda Y, Koizumi S, Takaue Y, Matsushita T, Fujimoto T, Misawa S.
    Leukemia; 1996 Sep 01; 10(9):1463-70. PubMed ID: 8751464
    [Abstract] [Full Text] [Related]

  • 18. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E, Hamed HB, Bakry RM, Ezz-Eldin AM, Khalifa NM.
    J Hematol Oncol; 2008 Oct 17; 1():17. PubMed ID: 18928518
    [Abstract] [Full Text] [Related]

  • 19. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
    Lin PC, Chang TT, Lin SR, Chiou SS, Jang RC, Sheen JM.
    Kaohsiung J Med Sci; 2008 Jun 17; 24(6):289-96. PubMed ID: 18635414
    [Abstract] [Full Text] [Related]

  • 20. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
    Tiensiwakul P.
    Cancer Genet Cytogenet; 2004 Feb 17; 149(1):85-8. PubMed ID: 15104290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.